The immune-mediated inflammatory diseases market encompasses treatments for chronic conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Market growth is driven by rising disease prevalence, improved diagnostic rates, and increasing use of biologics and targeted therapies. Pharmaceutical advancements are enhancing treatment efficacy and patient outcomes. https://www.databridgemarketresearch.com/reports/global-immune-mediated-inflammatory-diseases-market